SCHEMBL1027217

SCHEMBL1027217

CCCNCCOc1ccc(NS(=O)(=O)c2ccc([C@H](C)C(F)F)cc2)c(OC)n1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TRPV1 Q8NER1 12/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
F2 P00734 1/20 0.33
F10 P00742 1/20 0.33
PRSS1 P07477 1/20 0.33
PRSS2 P07478 1/20 0.33
PRSS3 P35030 1/20 0.33
ST14 Q9Y5Y6 1/20 0.33
SCN9A Q15858 1/20 0.33
CCR9 P51686 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
EDNRB P24530 1/20 0.33
EDNRA P25101 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1031793 1.00 LMNA (0.35) LMNATSHRHTTSMN1; SMN2TRPV1
Hydrochloric Acid SCHEMBL4244120 0.99 LMNA (0.34) LMNATSHRHTTSMN1; SMN2TRPV1
Hydrochloric Acid SCHEMBL4384753 0.99 LMNA (0.34) LMNATSHRHTTSMN1; SMN2TRPV1
SCHEMBL1032628 0.91 CYP2C19 (0.39) LMNATSHRHTTSMN1; SMN2TRPV1
SCHEMBL1032277 0.90 LMNA (0.35) LMNATSHRHTTSMN1; SMN2TRPV1
SCHEMBL4045301 0.90 LMNA (0.35) LMNATSHRHTTSMN1; SMN2TRPV1
SCHEMBL1031352 0.90 LMNA (0.35) LMNATSHRHTTSMN1; SMN2TRPV1
Hydrochloric Acid SCHEMBL4240630 0.90 CYP2C9 (0.39) LMNATSHRHTTSMN1; SMN2TRPV1
Hydrochloric Acid SCHEMBL4249141 0.89 LMNA (0.35) LMNATSHRHTTSMN1; SMN2TRPV1
Hydrochloric Acid SCHEMBL4249120 0.89 LMNA (0.35) LMNATSHRHTTSMN1; SMN2TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013179-B1 ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO KG (DE) 2011-01-19 EP disclosed